Patient Dosing Resumes in Alzheimer’s Clinical Trial
20 Janeiro 2022 - 3:48PM
AllPennyStocks.com
Treatments for Alzheimer’s continue to be lacking in the
clinical community. A drug repurposing by the pharmaceutical
company has the potential to be an effective treatment for mild
to...
To read the full story on AllPennyStocks.com, click
here.
Intelgenx Technologies (TSX:IGX)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Intelgenx Technologies (TSX:IGX)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024